This is a great opportunity to prove how valuable a collaboration between two international stem cell forces like Cellus and Global Stem Cells Group can be.
Miami, Fla. (PRWEB) September 28, 2015
Global Stem Cells Group has announced a new strategic alliance with Cellus to promote clinical research, physician training and patient treatment in Chile. Based in Santiago, Chile, Cellus is a stem cell company and full GMP lab dedicated to research, development and commercialization of therapeutic services and custom biotech products in the field of regenerative medicine.
Cellus’s state of the art medical facility, located at the Santiago Marriot, includes conference rooms with views to its cell culture lab and a full, cutting edge operating room for performing stem cell procedures. Cellus is managed by a multi-disciplinary team with extensive clinical experience and biopharmaceutical production, operating under the highest standards and international requirements for quality and safety. Cellus is continuously working to develop effective and innovative regenerative medicine solutions using autologous cellular therapies and biological products obtained from and administered to each individual patient.
“We are very pleased about our new alliance with Global Stem Cells Group,” says Cellus Commercial Manager Carlos Girardi. “We plan to leverage this alliance to further our clinical research, and to boost physician training here in Chile.
“This is a great opportunity to prove how valuable a collaboration between two international stem cell forces like Cellus and GSCG can be.”
Global Stem Cells Group, Chile CEO Enrique Testart agrees, adding that the new collaboration between the two companies will help GSCG establish itself as the leader in regenerative medicine therapies in Chile.
“Both Cellus and Global Stem Cells Group bring extraordinary insight, knowledge and experience in stem cell medicine to the table, and together we can accomplish great things,” Testart says. “I’m very excited to work with the excellent team at Cellus.”
The collaboration is part of Global Stem Cells Group’s push to highlight Chile’s appeal as a destination for patients seeking stem cell therapies for a variety of conditions, and as part of its ongoing commitment to expand the reach of stem cell treatments throughout Latin America.
To learn more, visit the Global Stem Cells Group website, email bnovas(at)regenestem(dot)com, or call 305-224-1858.
About the Global Stem Cells Group:
Global Stem Cells Group, Inc. is the parent company of six wholly owned operating companies dedicated entirely to stem cell research, training, products and solutions. Founded in 2012, the company combines dedicated researchers, physician and patient educators and solution providers with the shared goal of meeting the growing worldwide need for leading edge stem cell treatments and solutions. With a singular focus on this exciting new area of medical research, Global Stem Cells Group and its subsidiaries are uniquely positioned to become global leaders in cellular medicine.
Global Stem Cells Group’s corporate mission is to make the promise of stem cell medicine a reality for patients around the world. With each of GSCG’s six operating companies focused on a separate research-based mission, the result is a global network of state-of-the-art stem cell treatments.
Cellus is dedicated to research, development and commercialization of therapeutic services and custom biotech products in the field of regenerative medicine. Their multidisciplinary team of stem cell experts focus on the prevention and reversal of impairment in the skin of patients with traumatic injuries, skin diseases or symptoms of aging.
Their state-of-the-art facility in Santiago features a full laboratory and showcases the company’s extensive clinical expertise and biopharmaceutical production capabilities.